The new frontier in dementia detection

A free virtual workshop on December 1, 2021, from 12 to 1:30 p.m. explores how artificial intelligence and biomarkers can be used as the latest diagnostic tools for dementia detection. The event is sponsored by the Alzheimer's Association® and the Johns Hopkins Geriatric Workforce Enhancement Program. Register at https://www.communityresourcef... or by calling the 24/7 Helpline at 800-272-3900.

Dementia experts present
The discussion is led by Esther Oh, M.D., Ph.D., associate professor, Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, co-director, Johns Hopkins Memory and Alzheimer's Treatment Center; and Richard Keegan, Ph.D., regional medical director, Central Eastern US at Life Molecular Imaging. Emebong "Eme" Martin, MPH, regional director, Health Sytems: DC, MD & VA, Alzheimer's Association, is the moderator.

New ways to detect dementia
How brain imaging can identify and differentiate Alzheimer's from other neurocognitive diseases will be discussed along with the latest research on using artificial intelligence for diagnosing Alzheimer's disease in its earliest stages and predicting its progression. Another topic is the development of a blood-based biomarker of betamyloid protein in an oral glucose challenge test.

About the Alzhiemer's Association and Alzheimer's disease
There are more than 6 million people in the U.S. living with Alzheimer's disese and other dementia with more than 110,000 residing in Maryland. The Alzheimer's Association® is the world's leading voluntary health organization in Alzheimer's care, support and research, leading the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.